Ellora Parasite Control: Evidence Assessment
I cannot find any evidence in medical literature, FDA databases, or clinical guidelines regarding a product called "Ellora" for parasite control. This product does not appear in any peer-reviewed medical journals, FDA-approved drug databases, or established clinical practice guidelines for parasitic infections. 1, 2, 3
Evidence-Based Parasite Treatment Options
Since "Ellora" lacks any documented clinical evidence, here are the established, guideline-recommended treatments for common parasitic infections:
For Intestinal Parasites (Strongyloidiasis)
- Ivermectin 200 μg/kg orally for 2 consecutive days is the gold standard treatment, providing cure rates of 77-100% with excellent tolerability 2, 3
- For immunocompromised patients: ivermectin 200 μg/kg on days 1,2,15, and 16 2
- Albendazole 400 mg daily for 3 days is an alternative but significantly less effective (38-63% cure rate) 2
For Other Helminth Infections
- Albendazole or mebendazole as single-dose therapy is effective for soil-transmitted helminths (Ascaris, hookworm) 4, 5
- Praziquantel remains the most effective treatment for schistosomiasis 4
For Ectoparasites (Lice, Scabies)
- Permethrin is the treatment of choice in the US and Great Britain, with the best efficacy-to-safety profile 6
- Ivermectin 200 μg/kg as a single oral dose is effective for head lice when topical treatments fail 1
Critical Safety Warning
Never initiate corticosteroid therapy without first screening and treating for Strongyloides infection, as this can precipitate potentially fatal hyperinfection syndrome 2, 3
Clinical Recommendation
If you are considering "Ellora" for parasite control, I strongly recommend using one of the evidence-based treatments listed above instead, as they have documented efficacy, safety profiles, and FDA approval or guideline endorsement for specific parasitic infections 1, 2, 7.